Peter Finan is a Partner at Epidarex Capital, where he invests in early-stage through Series B companies across life sciences, health technology, pharmaceutical R&D, and drug discovery, including oncology, inflammation, regenerative medicine, respiratory disease, and autoimmunity. He invests across the United Kingdom, United States, Europe, the Middle East, and Africa. He serves on the board of Enterprise Therapeutics and has invested in companies like Epsilogen, Leucid Bio, AdoRx Therapeutics, Curve Therapeutics, and Lunac Therapeutics. Before Epidarex, he was CEO of AdoRx Therapeutics; earlier roles include Head of Biology at Karus Therapeutics; VP Global Head – Respiratory Disease, Executive Director, Director, and Project Leader at the Novartis Institutes for BioMedical Research; Lab Head and Project Leader at Novartis; and Postdoctoral Fellow at Cancer Research UK and Yamanouchi. Peter studied at the University of Leeds and lives in Edinburgh, Scotland, United Kingdom.
Peter Finan, Partner @ Epidarex. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Peter Finan from Epidarex Capital. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Peter
Map your path to Peter instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Peter
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.